Fatal Outcome for subcutaneous administration of Pegylated IFN alpha 2b in a man with Chronic C hepatitis under treatment with traditional bitherapy
Saved in:
| Main Authors: | Andrea Domínguez Gozalo, Francisco J. Hidalgo Correas, Elena García Benayas, Benito García Díaz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2015-02-01
|
| Series: | Farmacia Hospitalaria |
| Online Access: | http://www.aulamedica.es/fh/pdf/8572.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
by: Joana Vasconcelos, et al.
Published: (2022-01-01) -
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
by: Kata Ferenczi, et al.
Published: (2025-05-01) -
Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
by: Konstantinos D. Pantazis, et al.
Published: (2008-01-01) -
The remodeling of B-cell subsets was correlated with the clearance of hepatitis B antigen during pegylated IFN α-2a therapy in CHB patients
by: Lei Tan, et al.
Published: (2025-12-01) -
Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C
by: Priscilla C Hsu, et al.
Published: (2008-01-01)